WuXi Launches Commercial Website for Chemistry Products

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, today announced the launch of LabNetwork (www.labnetwork.com). LabNetwork is a global eCommerce platform for connecting buyers and sellers of research chemicals and reagents. Backed by WuXi's world-class expertise in chemistry R&D, sourcing, and quality control, LabNetwork will bring trusted, novel, and high-quality compounds from WuXi's global network of qualified providers to the chemistry and research communities worldwide.

For researchers and chemists, LabNetwork provides sophisticated web and mobile tools that allow customers to search for compounds by either keyword or chemical structure, with intelligent ranking of results. With a platform built for speed, ease of use, and big data, buyers can make informed decisions based upon cost, speed of delivery, and product quality. LabNetwork features multi-language, multi-currency, shopping cart, quote, checkout, and order tracking capabilities.

Suppliers will be able to leverage LabNetwork's customizable platform, global warehousing, logistics, and compliance solutions to reach new customers and markets. LabNetwork'€™s leadership team provides capabilities to increase distribution channels, author Safety Data Sheets in over 45 languages, and develop Global Harmonized System compliant labels.

LabNetwork currently offers nearly 300,000 research chemicals from more than a dozen quality suppliers, including the WuXi catalog of over 112,000 screening compounds, building blocks, and other off-the-shelf compounds. Many more supplier catalogs will be added in the coming months.

"LabNetwork will be a catalyst to enable more efficient and cost-effective research," said Dr. Ge Li, Chairman and CEO of WuXi PharmaTech. "This initiative is an important step in advancing WuXi's mission to broaden our service offerings and enable scientists anywhere in the world to leverage the LabNetwork platform to conduct their research more efficiently and cost effectively."

For more information, please contact:

Ronald Aldridge (for investors)
Director, Investor Relations
+1-201-585-2048
[email protected]

Aaron Shi (for the media)
Director, Corporate Communications
+86-21-5046-4362
[email protected]


At time of this announcement, the following suppliers are available on LabNetwork:

  • ChemBridge
  • Creasyn (青县科瑞希医药技术有限公司)
  • Frontier Scientific
  • Hanhong (上海瀚鸿化工科技有限公司)
  • Highfine (苏州昊帆生物科技有限公司)
  • Matrix Scientific
  • Sinocompound (江苏欣诺科催化剂有限公司)
  • Sinofluoro (上海恩氟佳科技有限公司)
  • Spectrum Chemical
  • SPC Scientific (南京盛必诚化工科技有限公司)
  • Titansci (上海泰坦科技股份有限公司)
  • WuXi AppTec (药明康德)

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.